JP2025508192A5 - - Google Patents
Info
- Publication number
- JP2025508192A5 JP2025508192A5 JP2024554912A JP2024554912A JP2025508192A5 JP 2025508192 A5 JP2025508192 A5 JP 2025508192A5 JP 2024554912 A JP2024554912 A JP 2024554912A JP 2024554912 A JP2024554912 A JP 2024554912A JP 2025508192 A5 JP2025508192 A5 JP 2025508192A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrocarbyl
- membered
- general formula
- optionally substituted
- halohydrocarbyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210266719.4 | 2022-03-17 | ||
| CN202210266719 | 2022-03-17 | ||
| PCT/CN2023/080775 WO2023174175A1 (zh) | 2022-03-17 | 2023-03-10 | Kif18a抑制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508192A JP2025508192A (ja) | 2025-03-21 |
| JP2025508192A5 true JP2025508192A5 (https=) | 2026-03-18 |
Family
ID=88022235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554912A Pending JP2025508192A (ja) | 2022-03-17 | 2023-03-10 | Ｋｉｆ１８ａ阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250197382A1 (https=) |
| EP (1) | EP4495113A4 (https=) |
| JP (1) | JP2025508192A (https=) |
| CN (1) | CN118613478A (https=) |
| AU (1) | AU2023236101A1 (https=) |
| CA (1) | CA3246028A1 (https=) |
| WO (1) | WO2023174175A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250027560A (ko) * | 2022-06-30 | 2025-02-26 | 쑤저우 젠하우스 바이오 컴퍼니 리미티드 | 질소 함유 화합물 및 이의 용도 |
| WO2024022508A1 (zh) * | 2022-07-29 | 2024-02-01 | 武汉人福创新药物研发中心有限公司 | Kif18a抑制剂及用途 |
| TW202416973A (zh) | 2022-08-18 | 2024-05-01 | 美商雅客森醫療公司 | Ｋｉｆ１８ａ抑制劑及其用途 |
| KR20250044780A (ko) * | 2022-09-08 | 2025-04-01 | 장춘 진사이언스 파마슈티컬 씨오., 엘티디. | Kif18a 억제제 화합물, 약제학적 조성물 및 이의 제조 방법과 적용 |
| CN119907796A (zh) * | 2022-09-09 | 2025-04-29 | 海南先声再明医药股份有限公司 | 酰胺类化合物、其组合物及用途 |
| CN119562952A (zh) * | 2022-09-30 | 2025-03-04 | 山东轩竹医药科技有限公司 | Kif18a抑制剂 |
| WO2024083208A1 (zh) * | 2022-10-21 | 2024-04-25 | 杭州邦顺制药有限公司 | Kif18a蛋白抑制剂 |
| JP2025538601A (ja) * | 2022-11-24 | 2025-11-28 | インベンティスバイオ カンパニー リミテッド | 複素環化合物、その製造方法および用途 |
| EP4628486A1 (en) * | 2022-12-02 | 2025-10-08 | Shenzhen Zhongge Biological Technology Co., Ltd. | Amide or urea compound |
| CN120641408A (zh) * | 2022-12-16 | 2025-09-12 | 抟相医药(上海)有限公司 | 含氮化合物、药物组合物及其用途 |
| WO2024140799A1 (en) * | 2022-12-28 | 2024-07-04 | Insilico Medicine Ip Limited | Inhibitors of kif18a and uses thereof |
| WO2024149189A1 (zh) * | 2023-01-09 | 2024-07-18 | 浙江海正药业股份有限公司 | 芳香酰胺类衍生物及其制备方法和用途 |
| JP2026509288A (ja) * | 2023-03-10 | 2026-03-17 | 浙江海正薬業股▲ふん▼有限公司 | 芳香族アミド誘導体、その製造方法、およびその使用 |
| WO2024217348A1 (zh) * | 2023-04-18 | 2024-10-24 | 南京同诺康医药科技有限公司 | Kif18a抑制剂及其制备方法和用途 |
| WO2025167861A1 (zh) * | 2024-02-06 | 2025-08-14 | 上海齐鲁制药研究中心有限公司 | 螺环kif18a抑制剂 |
| WO2025190364A1 (zh) * | 2024-03-14 | 2025-09-18 | 山东轩竹医药科技有限公司 | Kif18a抑制剂及其用途 |
| WO2025201531A1 (zh) * | 2024-03-29 | 2025-10-02 | 深圳众格生物科技有限公司 | 三环类化合物及其用途 |
| WO2025242166A1 (en) * | 2024-05-22 | 2025-11-27 | InventisBio Co., Ltd. | Heterocyclic compounds, preparation methods and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA54543A (fr) * | 2018-12-20 | 2022-03-30 | Amgen Inc | Inhibiteurs de kif18a |
| AU2019401495B2 (en) * | 2018-12-20 | 2025-06-26 | Amgen Inc. | Heteroaryl amides useful as KIF18A inhibitors |
| JP7686559B2 (ja) * | 2018-12-20 | 2025-06-02 | アムジエン・インコーポレーテツド | Ｋｉｆ１８ａ阻害剤 |
| EP4007638A1 (en) * | 2019-08-02 | 2022-06-08 | Amgen Inc. | Pyridine derivatives as kif18a inhibitors |
| EP4007752B1 (en) * | 2019-08-02 | 2025-09-24 | Amgen Inc. | Kif18a inhibitors |
| EP4007753B1 (en) * | 2019-08-02 | 2025-09-24 | Amgen Inc. | Kif18a inhibitors |
| MX2022012992A (es) * | 2020-04-14 | 2022-11-08 | Amgen Inc | Inhibidores de kif18a para el tratamiento de enfermedades neoplasicas. |
| TW202400582A (zh) * | 2022-05-13 | 2024-01-01 | 大陸商上海湃隆生物科技有限公司 | 驅動蛋白kif18a抑制劑及其應用 |
-
2023
- 2023-03-10 JP JP2024554912A patent/JP2025508192A/ja active Pending
- 2023-03-10 WO PCT/CN2023/080775 patent/WO2023174175A1/zh not_active Ceased
- 2023-03-10 US US18/845,669 patent/US20250197382A1/en active Pending
- 2023-03-10 CA CA3246028A patent/CA3246028A1/en active Pending
- 2023-03-10 CN CN202380018165.9A patent/CN118613478A/zh active Pending
- 2023-03-10 AU AU2023236101A patent/AU2023236101A1/en active Pending
- 2023-03-10 EP EP23769679.4A patent/EP4495113A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025508192A5 (https=) | ||
| JP2023515617A5 (https=) | ||
| KR102244937B1 (ko) | 글리옥사미드 치환된 피롤아미드 유도체 및 ｂ형 간염 치료용 의약으로서의 이의 용도 | |
| JP2024522990A5 (https=) | ||
| CA2850166C (en) | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer | |
| AU2005202964B2 (en) | Pharmaceutically active isoindoline derivatives | |
| JP2024529839A5 (https=) | ||
| JP2019536785A5 (https=) | ||
| JP2024530952A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2024510274A5 (https=) | ||
| EP1240160A1 (en) | Substituted pyridazines having cytokine inhibitory activity | |
| JP2016500661A5 (https=) | ||
| AR054787A1 (es) | Derivados de piperidinas utiles como antagonistas de histamina h3 | |
| JP2017526614A5 (https=) | ||
| JP2021522262A5 (https=) | ||
| JP2024536869A5 (https=) | ||
| JP2005513125A5 (https=) | ||
| JP2021528405A5 (https=) | ||
| JP2009532417A5 (https=) | ||
| JP2025509697A5 (https=) | ||
| JP2023528421A5 (https=) | ||
| JP2023516235A5 (https=) | ||
| RU2002133208A (ru) | Замещенные 1-аминоалкиллактамы и их применение в качестве антагонистов мускариновых рецепторов | |
| JP2019501927A5 (https=) |